People channel feed

Help want­ed: New CEO to run Gilead as John Mil­li­gan steps down

7 years ago

Za­vante CEO sells his late-stage an­tibi­ot­ic biotech to Nabri­va — grab­bing the helm in the deal

7 years ago
Pharma

Il­lu­mi­na's found­ing sci­en­tist launch­es soft­ware start­up to track fast-mu­tat­ing hos­pi­tal bugs

7 years ago
Startups

Hu­man Longevi­ty blasts Craig Ven­ter, claim­ing he was fired, then stole trade se­crets — poach­ing staffers for ri­val op­er­a­tion

7 years ago

Bio­gen vet George Scan­gos jumps on the board at up­start MS case man­ag­er Oc­tave, backed by Sec­tion 32

7 years ago
Financing

Genen­tech vet Myr­tle Pot­ter takes a lead­ing role in Vivek Ra­maswamy's fast-mov­ing Vant ops

7 years ago
R&D

Ap­peas­ing ac­tivist in­vestors, Iron­wood cuts 40 staffers at the start of com­pa­ny split

7 years ago
R&D
Pharma

Trump in­vites phar­ma heads to pri­vate din­ner dur­ing Lon­don vis­it, a trip that's in­spir­ing tens of thou­sands to protest

7 years ago
Pharma

Is Mar­tin Shkre­li blog­ging from prison?

7 years ago

'Bio­hack­er' Tray­wick ac­ci­den­tal­ly drowned, of­fi­cial con­firms

7 years ago

Af­ter biotech im­plo­sions, ex-Mil­len­ni­um chief Deb­o­rah Dun­sire is tak­ing the helm at Lund­beck

7 years ago

Sar­co­ma ex­pert George Demetri grades the lat­est state­ment on Nanobi­otix's late-stage drug NBTXR3

7 years ago
R&D
Pharma

Meet Jen­nifer Pet­ter: Boston start­up Ar­rakis cel­e­brates a big per­son­al tran­si­tion for top ex­ec

7 years ago

In high-lev­el reshuf­fle, Roche gives James Sabry the glob­al reins on deal-mak­ing — over­see­ing pRED and gRED

7 years ago
Peer Review

Ex-Puma ex­ec sen­tenced to prison stretch on in­sid­er-trad­ing con­vic­tion — 'greed' made me do it

7 years ago
Pharma

Buf­fett, Di­mon and Be­zos find their mir­a­cle man, charged with fix­ing a bro­ken health­care sys­tem

7 years ago

From top an­a­lyst to CFO: Cowen’s Er­ic Schmidt leaps in­to the top ranks of biotech’s lat­est overnight sen­sa­tion

7 years ago

For­mer biotech an­a­lyst Ja­son Napo­dano sen­tenced to a short stretch in a fed­er­al prison for se­cu­ri­ties fraud

7 years ago

Blame the ozan­i­mod fi­as­co on the Re­cep­tos team? Just wait a sec, says ex-CEO, who sold the com­pa­ny to Cel­gene for $7.2B

7 years ago
Pharma

Promi­nent can­cer bi­ol­o­gist In­der Ver­ma re­signs from Salk in wake of sex­u­al ha­rass­ment al­le­ga­tions

7 years ago

GSK’s high-lev­el man­age­ment makeover con­tin­ues as CEO Em­ma Walm­s­ley over­sees chang­ing of the guard

7 years ago

Af­ter cash fun­nel­ing scan­dal, biotech bil­lion­aire Soon-Sh­iong charges on with Nant IPO

7 years ago
Financing

On an ex­ec­u­tive hir­ing spree, Sarep­ta snags Bio­gen's Gilmore O'Neill as new CMO

7 years ago

No­to­ri­ous ac­tivist in­vestor Carl Ic­ahn buys small stake in Al­ler­gan

7 years ago
First page Previous page 86878889909192 Next page Last page
A service from the Financial Times